We are live on ! Find out more
TCON

TRACON Pharmaceuticals, Inc. Common Stock

Delisted

TCON was delisted on the 27th of June, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
IC
1
Ikarian Capital
Texas
$17.6M
OM
2
Opaleye Management
Massachusetts
$16.3M
Vanguard Group
3
Vanguard Group
Pennsylvania
$4.47M -$28.9K -209 -0.6%
NMC
4
NEA Management Company
Maryland
$2.25M
BlackRock
5
BlackRock
New York
$1.91M -$220K -1,588 -10%
BFM
6
Boothbay Fund Management
New York
$1.91M
LA
7
Linden Advisors
New York
$1.84M
Two Sigma Advisers
8
Two Sigma Advisers
New York
$1.84M -$161K -1,165 -8%
Deutsche Bank
9
Deutsche Bank
Germany
$1.65M
Two Sigma Investments
10
Two Sigma Investments
New York
$1.62M -$411K -2,971 -19%
Renaissance Technologies
11
Renaissance Technologies
New York
$1.13M -$464K -3,353 -28%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$894K +$227K +1,643 +31%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$553K
JJIJ
14
Johnson & Johnson Innovation - JJDC
New Jersey
$545K
State Street
15
State Street
Massachusetts
$473K +$505K +3,648 New
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$372K +$397K +2,867 New
Marshall Wace
17
Marshall Wace
United Kingdom
$366K -$588K -4,250 -60%
QI
18
QS Investors
New York
$284K
DY
19
Dowling & Yahnke
California
$263K
TI
20
Telemetry Investments
New York
$260K +$277K +2,000 New
GCP
21
GSA Capital Partners
United Kingdom
$236K +$74.1K +536 +42%
Acadian Asset Management
22
Acadian Asset Management
Massachusetts
$217K +$65.6K +474 +40%
SFI
23
Susquehanna Fundamental Investments
Pennsylvania
$205K -$6.78K -49 -3%
ACM
24
ACT Capital Management
Pennsylvania
$185K +$197K +1,425 New
XSC
25
X-Square Capital
Puerto Rico
$136K